Syneos Health, Inc.·4

Mar 4, 5:05 PM ET

KEEFE MICHELLE 4

4 · Syneos Health, Inc. · Filed Mar 4, 2022

Insider Transaction Report

Form 4
Period: 2022-03-02
KEEFE MICHELLE
Pres., Commercial Solutions
Transactions
  • Award

    Class A Common Stock

    2022-03-02+7,84554,156 total
  • Award

    Class A Common Stock

    2022-03-02+2,15858,311 total
  • Award

    Class A Common Stock

    2022-03-02+1,99756,153 total
  • Tax Payment

    Class A Common Stock

    2022-03-02$80.75/sh5,289$427,08753,022 total
Footnotes (4)
  • [F1]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021.
  • [F2]Includes 84 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2022.
  • [F3]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2022, subject to continued employment.
  • [F4]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION